Aptamers the chemical antibodies

Antibodies Applications and New Development

Volumn , Issue , 2012, Pages 300-314

  Houwen, Frans P ^a   Kage, Andreas ^b,c  

^a ScienceLynk BV   (Netherlands)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c AptaRes AG   (Germany)

Author keywords

Application; Aptamers; Chemical antibodies; Development

Indexed keywords

EID: 84860244422     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805264611201010300     Document Type: Chapter

References (67)

1. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346: 818-22.
2. Hermann T, Patel DJ. Adaptive recognition by nucleic acid aptamers. Science 2000; 287: 820-5.
3. Li T, Li B, Dong S. Adaptive recognition of small molecules by nucleic acid aptamers through a label-free approach. Chem Eur J 2007; 13: 6718-23.
4. Jayasena SD. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 1999; 45: 1628-50.
5. Rimmele M. Nucleic acid aptamers as tools and drugs: recent developments. ChemBioChem 2003; 4: 963-71.
6. Ruta J, Rabvelet C, Grosset C, et al. Enantiomeric separation using an L-RNA aptamer as chiral additive in partial-filling capillary electrophoresis. Anal Chem 2006; 78: 3032-39.
7. Cercia L, Hamm J, Libri D, Tavitian B, de Franciscis, V. Nucleic acid aptamers in cancer medicine. FEBS Letters 2002; 528: 12-16.
8. Joyce GF. Building the RNA world: evolution of catalytic RNA in the laboratory. In: Cech TR, Ed. Molecular biology of RNA, UCLA symposia on molecular and cellular biology, new series; 94 - proceedings of a director's sponsors-UCLA symposium held at Keystone Colorado April 4 - 10 1988. New York, Alan R Liss Inc, 1989; pp. 361-71.
9. Joyce GF. Amplification mutation and selection of catalytic RNA. Gene 1989; 82: 83-87.
10. Yarus M. A specific amino acid binding site composed of RNA. Science 1988; 240: 1751-58.
11. Yarus M. A stereoselective binding site for arginine on Tetrahymena self-splicing intron. In: Cech TR, Ed. Molecular biology of RNA, UCLA symposia on molecular and cellular biology, new series; 94 - proceedings of a director's sponsors-UCLA symposium held at Keystone Colorado April 4 - 10 1988. New York, Alan R Liss Inc, 1989; pp. 373-74.
12. Mendonsa SD, Bowser MT. In vitro selection of aptamers with affinity for neuropeptide Y using capillary electrophoresis. J Am Chem Soc 2005; 127: 9382-83.
13. Berezovski M, Drabovich A, Krylova SM, et al. Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. J Am Chem Soc 2005; 127: 3165-71.
14. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505-10.
15. Nitsche A, Kurth A, Dunkhorst A, et al. One-step selection of Vaccinia virus-binding DNA aptamers by MonoLex. BMC Biotechnol 2007; 7: 48-59.
16. Mendonsa SD, Bowser MT. In vitro evolution of functional DNA using capillary electrophoresis. J Am Chem Soc 2004; 126: 20-21.
17. Qian J, Lou X, Zhang Y, Xiao Y, Soh HT. Generation of highly specific aptamers via micromagnetic selection. Anal Chem 2009; 81: 5490-95.
18. Stoltenburg R, Reinemann C, Strehlitz B. FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal Bioanal Chem 2005; 383: 83-91.
19. Shamah SM, Healy JM, Cload ST. Complex target SELEX. Acc Chem Res 2008; 41:130-38.
20. Gopinath SCB. Methods developed for SELEX. Anal Bioanal Chem 2007; 387: 171-82.
21. Lou X, Qian J, XiaoY, et al. Micromagnetic selection of aptamers in microfluidic channels. Proc Natl Acad Sci USA 2009; 106: 2989-94.
22. Blank M, Weinschenk T, Priemer M, Schluesener H. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. J Biol Chem 2001; 276: 16464-68.
23. Yang X, Li X, Prow T, et al. Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers. Nucleic Acids Res 2003; 31: e54.
24. Misono TS, Kumar PKR. Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Anal Biochem 2005; 342: 312-17.
25. Turgeon RT, Fonslow BR, Jing M, Bowser MT. Measuring aptamer equilibria using gradient micro free flow electrophoresis. Anal Chem 2010; 82: 3636-41.
26. Cho M, Xiao Y, Nie J, et al. Quantitative selection of DNA aptamers through microfluidic selection and highthroughput sequencing. Proc Nat Acad Sci USA 2010; 107: 15373-78.
27. Drabovich A, Berezovski M, Krylov SN. Selection of smart aptamers by equilibrium capillary electrophoresis of equilibrium mixtures (ECEEM). J Am Chem Soc 2005; 127: 11224-25.
28. German I, Buchanan DB, Kennedy RT. Aptamers as ligands in affinity probe capillary electrophoresis. Anal Chem 1998; 70: 4540-45.
29. Haes AJ, Giordano BC, Collins GE. Aptamer-based detection and quantitative analysis of ricin using affinity probe capillary electrophoresis. Anal Chem 2006; 78: 3758-64.
30. Mosing RK, Mendonsa SD, Bowser MT. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal Chem 2005; 77: 6107-12.
31. Jenison RD, Gill SC, Pardi A, Polisky B. High-resolution Molecular discrimination by RNA. Science 1994; 263: 1425-29.
32. Srinivasan J, Cload ST, Hamaguchi N, et al. ADP-specific sensors enable universal assay of protein kinase activity. Chem Biol 2004; 11: 499-08.
33. Shangguan D, Cao Z, Meng L, et al. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res 2008; 7: 2133-39.
34. Ulrich H, Wrengler C. Disease-specific biomarker discovery by aptamers. Cytometry Part A 2009; 75A: 727-33.
35. Torres-Chavolla E, Alocilja EC. Aptasensors for detection of microbial and viral pathogens. Biosens Bioelectron 2009; 24: 3175-82.
36. Lau IPM, Ngan EKS, Loo JFC, Suen YK, Ho HP, Kong SK. Aptamer-based bio-barcode assay for the detection of cytochrome-c released from apoptotic cells. Biochem Biophys Res Com 2010: 395: 560-64.
37. Morris KN, Jensen KB, Julin CM, Weil M, Gold L. High affinity ligands from in vitro selection: complex targets. Proc Nat Acad Sci USA 1998; 95: 2902-07.
38. Bouchard PR, Hutabarat RM, Thompson KM. Discovery and development of therapeutic aptamers. Annu Rev Pharmacol Toxicol 2010; 50: 237-57.
39. Sassanfar M, Szostak JW. An RNA motif that binds ATP. Nature 1993; 364: 550-53.
40. Famulok M. Molecular recognition of amino acids by RNA-aptamers: an L-citrulline binding RNA motif and its evolution into an L-arginine binder. J Am Chem Soc 1994; 116: 1698-06.
41. Geiger A, Burgstaller P, Eltz HVD. RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res 1996; 24: 1029-36.
42. Liu J, Cao Z, lu Y. Functional nucleic acid sensors. Chem Rev 2009; 109: 1948-98.
43. Hianik T, Wang J. Electrochemical aptasensors - recent achievements and perspectives. Electroanalysis 2009; 11: 1223-35.
44. Han K, Liang Z, Zhou N. Design strategies for aptamer-based bioensors. Sensors 2010; 10: 4541-57.
45. Sassolas A, Blum LJ, Leca-Bouvier BD. Electrochemical aptasensors. Electroanalysis 2009; 21: 1237-50.
46. Song S, Wang L, Li J, Zhao J, Fan CY. Aptamer-based biosensors. Trends Anal Chem 2008; 27: 108-17.
47. Lee J-O, So H-M, Jeon E-K, Chang H, Won K, Kim YH. Aptamers as molecular recognition elements for electrical nanobiosensors. Anal Bioanal Chem 2008; 390: 1023-32.
48. Schlecht U, Malavé A, Gronewold T, Tewes M, Löhndorf M. Comparison of antibody and aptamer receptors for the specific detection of thrombin with nanometer gap-sized impedance biosensors. Anal Chim Acta 2006; 573-574: 65-68.
49. Yao C, Zhu T, Qi Y, Zhao Y, Xia H, Fu W. Development of a Quartz crystal microbalance biosensor with aptamers as bio-recognition element. Sensors 2010; 10: 5859-71.
50. Strehlitz B, Nikolaus N, Stoltenburg R. Protein detection with aptamer biosensors. Sensors 2008; 8: 4296-07.
51. Radi A-E, Sánchez JLA, Baldrich E, O'Sullivan CK. Reagentless reusable ultrasensitive electrochemical molecular beacon aptasensor. J Am Chem Soc 2006; 128: 117-24.
52. So H-M, Won K, Kim YH, et al. Single-walled carbon nanotube biosensors using aptamers as molecular recognition elements. J Am Chem Soc 2005; 127: 11906-07.
53. Zhang Y-L, Huang Y-F, Jiang J-H, Shen G.-L, Yu R-Q Electrochemical aptasensor based on proximitydependent surface hybridization assay for single-step reusable, sensitive protein detection. J Am Chem Soc 2007; 129: 15448-49.
54. Lai RY, Plaxco KW, Heeger AJ. Aptamer-based electrochemical detection of picomolar platelet-derived growth factor directly in blood serum. Anal Chem 2007; 79: 229-33.
55. Ng EW, Shima DT, Calias P, Cunningham ET, Guyer DR, Adamis AP. Pegaptanib a targeted anti- VEGF aptamer for ocular vascular disease. Nature Rev Drug Discov 2006; 5: 123-32.
56. Thiel KW, Giangrande PH. Therapeutic applications of DNA and RNA aptamers. Oligonucleotides 2009; 19: 209-22.
57. Famulok M, Hartig JS, Mayer G. Functional aptamers and aptazymes in biotechnology diagnostics and therapy. Chem Rev 2007; 107: 3715-43.
58. Healy JM, Lewis SD, Kurtz M, et al. Pharmacokinetics and biodistribution of novel aptamer compositions. Pharm Res 2004; 21: 2234-46.
59. Hicke BJ, Watson SR, Koenig A, et al. DNA aptamers block L-selectin function in vivo Inhibition of human lymphocyte trafficking in SCID mice. J Clin Invest 1996; 98: 2688-92.
60. Willis MC, Collins B, Zhang T, et al. Liposome-anchored vascular endothelial growth factors aptamers. Bioconjugate Chem 1998; 9: 573-82.
61. Zendegui JG, Vasquez KM, Tinsley JH, Kessler DJ, Hogan ME. In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides. Nucleic Acids Res 1992; 20: 307-14.
62. Eulberg D, Klussmann S. Spiegelmers: biostable aptamers. ChemBioChem 2003; 4: 979-83.
63. Di Giusto DA, King GC. Construction stability and activity of multivalent circular anticoagulant aptamers. J Biol Chem 2004; 279: 46483-89.
64. Keefe AD, Cload ST. SELEX with modified nucleotides. Curr Opin Chem Biol 2008; 12: 448-56.
65. Rusconi CP, Scardino E, Layzer J, et al. RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 2002; 419: 90-94.
66. Rusconi CP, Roberts JD, Pitoc GA, et al. Antidote-mediated control of an anticoagulant aptamer in vivo. Nat Biotechnol 2004; 22: 1423-28.
67. Oney S, Lam RTS, Bompiani KM, et al. Development of universal antidotes to control aptamer activity. Nat Med 2009; 15: 1224-28.h.